Forte Biosciences, Inc. — Director's Dealing 2021

Sep 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Forte Biosciences, Inc. (FBRX)
CIK: 0001419041
Period of Report: 2021-09-07

Reporting Person: Riley Antony A (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-07	Common Stock	S	21484	$4.24	Disposed	14581	Direct
2021-09-07	Common Stock	S	3516	$4.27	Disposed	11065	Direct